X4 Pharmaceuticals, Inc.

XFOR Healthcare Biotechnology

In the quarter to June 2026, revenue grew 346.3%, EPS grew 96.3%, free cash flow grew 13.8% and total debt rose 1.21%, each against the same quarter a year earlier.

2.59 0.05 −1.89%
Market cap
$261.8M
P/E
0.0×
Fwd P/E
−5.1×
Dividend yield
—
F-score
n/a
Altman Z
−1.78
Beneish M
8.05
Dividend safety
n/a

A Balance Sheet is a financial statement that provides a snapshot of a company's assets, liabilities, and shareholders' equity at a specific point in time. It follows the formula: Assets = Liabilities + Shareholders' Equity. Key components include current and non-current assets, current and long-term liabilities, and equity. The Balance Sheet helps businesses and investors evaluate financial stability, liquidity, and capital structure. It's essential for assessing the company's ability to meet its obligations and fund future operations.

Dec '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 Dec '18 Dec '17 Dec '16
Total current assets
261.58 112.18 122.08 128.68 87.88 83.31 129.28 9.34 79.53 5.72
Total non-current assets
28.88 34.27 25.18 26.91 29.30 39.56 31.42 0.61 1.72 1.89
Total Assets
290.46 146.45 147.26 155.59 117.18 122.87 160.70 9.94 81.25 7.60
Total current liabilities
25.76 32.88 22.86 22.32 14.02 11.95 9.45 7.91 10.68 12.06
Total non-current liabilities
78.41 91.42 73.30 59.21 38.74 38.12 22.03 14.45 11.87 12.27
Total liabilities
104.17 124.30 96.16 81.54 52.76 50.07 31.48 22.36 22.55 24.33
Common Equity (Total)
186.29 22.15 51.10 74.05 64.41 72.80 129.22 (77.09) 58.71 (56.56)
Shareholders Equity (Total)
186.29 22.15 51.10 74.05 64.41 72.80 129.22 (12.41) 58.71 (16.72)
Total Debt
76.29 75.43 54.57 33.62 33.93 33.18 21.00 9.83 9.92 10.13

Show all line items

In millions of $ except per-share values · columns are period end dates